Natural trans fat may not boost "bad" cholesterol
NEW YORK (Reuters Health) - The artificial trans fats that once abounded in processed foods have become notorious for their undesirable effects on cholesterol levels. But a small clinical trial suggests that natural trans fats may not do the same damage. When 61 healthy women followed a diet with a hefty dose of natural trans fats for four weeks, researchers found there were no changes in the ...
Read more...
Be heart-healthy and have your eggs, too
Extension agent Susan Johnson talks about the ins and outs of eggs.
Read more...
FDA Rejects Proposed Chronic Kidney Disease Indication for Vytorin
The FDA rejected a new indication for Merck's Vytorin and Zetia (ezetimibe plus simvastatin and ezetimibe alone) in chronic kidney disease patients. As a consolation prize, however, the agency approved a new label for Vytorin that will incorporate the results of SHARP (Study of Heart and Renal Protection), which found that Vytorin reduced the incidence of major vascular events in patients with ...
Read more...
Press Release
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved an updated label for VYTORIN® (ezetimibe/simvastatin) that includes results from the S tudy of H eart a nd R enal P rotection (SHARP). In SHARP, VYTORIN 10/20 mg lowered LDL cholesterol in patients with moderate to severe chronic kidney disease (CKD ...
Read more...
New FDA Approved Labeling For VYTORIN® (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal ...
Merck , known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has approved an updated label for VYTORIN® that includes results from the Study of Heart and Renal Protection .
Read more...
|